Annual ROE
103.13%
-305.40%-74.76%
September 30, 2024
Summary
- As of February 7, 2025, OTLK annual return on equity is 103.13%, with the most recent change of -305.40% (-74.76%) on September 30, 2024.
- During the last 3 years, OTLK annual ROE has risen by +1257.00% (+108.94%).
- OTLK annual ROE is now -89.99% below its all-time high of 1030.41%, reached on September 30, 2016.
Performance
OTLK ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
95.60%
-50.96%-34.77%
September 1, 2024
Summary
- As of February 7, 2025, OTLK quarterly return on equity is 95.60%, with the most recent change of -50.96% (-34.77%) on September 1, 2024.
- Over the past year, OTLK quarterly ROE has dropped by -513.92% (-84.32%).
- OTLK quarterly ROE is now -87.57% below its all-time high of 769.24%, reached on December 31, 2020.
Performance
OTLK Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
OTLK ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -74.8% | -84.3% |
| 3 y3 years | +108.9% | +112.4% |
| 5 y5 years | -67.8% | -62.3% |
OTLK ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -74.8% | +108.9% | -84.3% | +102.6% |
| 5 y | 5-year | -74.8% | +108.3% | -87.6% | +102.6% |
| alltime | all time | -90.0% | +108.3% | -87.6% | +102.6% |
Outlook Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | 103.13%(-74.8%) | - |
| Sep 2024 | - | 95.60%(-34.8%) |
| Jun 2024 | - | 146.56%(-58.9%) |
| Mar 2024 | - | 356.56%(-41.5%) |
| Dec 2023 | - | 609.52%(-116.3%) |
| Sep 2023 | 408.53%(-154.0%) | -3741.55%(+357.0%) |
| Jun 2023 | - | -818.68%(+97.0%) |
| Mar 2023 | - | -415.52%(+19.1%) |
| Dec 2022 | - | -348.90%(+50.0%) |
| Sep 2022 | -756.04%(-34.5%) | -232.57%(-2.2%) |
| Jun 2022 | - | -237.90%(+1.6%) |
| Mar 2022 | - | -234.06%(-4.4%) |
| Dec 2021 | - | -244.94%(-68.3%) |
| Sep 2021 | -1153.87%(-7.5%) | -772.36%(+0.1%) |
| Jun 2021 | - | -771.68%(+14.2%) |
| Mar 2021 | - | -675.89%(-187.9%) |
| Dec 2020 | - | 769.24%(+75.4%) |
| Sep 2020 | -1246.84% | 438.58%(+41.6%) |
| Jun 2020 | - | 309.73%(+22.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | 253.81%(-7.1%) |
| Dec 2019 | - | 273.25%(+12.1%) |
| Sep 2019 | 320.56%(+121.7%) | 243.79%(+11.0%) |
| Jun 2019 | - | 219.70%(+0.9%) |
| Mar 2019 | - | 217.82%(-4.0%) |
| Dec 2018 | - | 226.98%(+0.4%) |
| Sep 2018 | 144.60%(+14.4%) | 226.07%(+47.1%) |
| Jun 2018 | - | 153.68%(+50.4%) |
| Mar 2018 | - | 102.20%(+11.3%) |
| Dec 2017 | - | 91.81%(-36.0%) |
| Sep 2017 | 126.44%(-87.7%) | 143.42%(-31.0%) |
| Jun 2017 | - | 207.94%(-54.7%) |
| Mar 2017 | - | 459.24%(-5.1%) |
| Dec 2016 | - | 483.87%(-18.1%) |
| Sep 2016 | 1030.41%(+521.9%) | 590.58%(+46.7%) |
| Jun 2016 | - | 402.47%(+67.6%) |
| Mar 2016 | - | 240.18%(-17.8%) |
| Dec 2015 | - | 292.18%(+76.3%) |
| Sep 2015 | 165.70%(+245.1%) | 165.70% |
| Sep 2014 | 48.01% | - |
FAQ
- What is Outlook Therapeutics annual return on equity?
- What is the all time high annual ROE for Outlook Therapeutics?
- What is Outlook Therapeutics annual ROE year-on-year change?
- What is Outlook Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Outlook Therapeutics?
- What is Outlook Therapeutics quarterly ROE year-on-year change?
What is Outlook Therapeutics annual return on equity?
The current annual ROE of OTLK is 103.13%
What is the all time high annual ROE for Outlook Therapeutics?
Outlook Therapeutics all-time high annual return on equity is 1030.41%
What is Outlook Therapeutics annual ROE year-on-year change?
Over the past year, OTLK annual return on equity has changed by -305.40% (-74.76%)
What is Outlook Therapeutics quarterly return on equity?
The current quarterly ROE of OTLK is 95.60%
What is the all time high quarterly ROE for Outlook Therapeutics?
Outlook Therapeutics all-time high quarterly return on equity is 769.24%
What is Outlook Therapeutics quarterly ROE year-on-year change?
Over the past year, OTLK quarterly return on equity has changed by -513.92% (-84.32%)